Outcome 1 year after ICH: Data from the Tranexamic acid for IntraCerebral Haemorrhage 2 (TICH-2) trial.

Zhe Kang Law Chaamanti Sivakumar Menon Lisa Jane WoodhouseJason Philip AppletonRustam Al-Shahi SalmanThompson RobinsonDavid WerringChristine RoffeRobert A DineenPhilip Michael BathNikola Sprigg

Published in: European stroke journal (2024)

There was no difference in functional outcome at 1 year after ICH. Tranexamic acid may reduce mortality at 1 year without an increase in severely dependent survivors. But this should be interpreted with caution as this is a result of secondary analysis in a neutral trial.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
young adults
electronic health record
cardiovascular events
open label
risk factors
randomized controlled trial
machine learning
data analysis
coronary artery disease
deep learning
double blind